CDC Vaccine Recommendations Are at a Standstill, and Unanswered Questions Are Piling up
The agency kept last year’s flu guidance after legal uncertainty halted the normal review process, leaving an FDA-approved vaccine off the fall list.
- The Centers for Disease Control and Prevention quietly decided this month to maintain last year's flu vaccine endorsements, excluding the new mFlusiva shot for adults aged 50 to 64 due to "legal uncertainties and inquiries."
- Health Secretary Robert F. Kennedy Jr.'s efforts to overhaul vaccine policy disrupted the 60-year-old Advisory Committee on Immunization Practices , prompting a federal judge to halt his changes after medical groups filed lawsuits.
- With federal guidance stalled, medical societies are issuing their own vaccine recommendations to fill the gap, and the trade association for private health insurers decided to heed these independent choices to ensure continued coverage.
- An alliance of 15 Democratic state governors warned that hastily made federal changes are likely to increase administrative complexity and confusion, with residents bearing the brunt of any increased disease outbreaks.
- Experts note the credibility of the Trump administration regarding vaccine recommendations is compromised, with public health communities viewing potential future policy changes with skepticism as the government weighs new categories for federal vaccine guidance.
35 Articles
35 Articles
CDC vaccine policy recommendations grind to a halt under Health Secretary Kennedy - WSVN 7News | Miami News, Weather, Sports
NEW YORK (AP) — The Food and Drug Administration recently approved a new flu vaccine that tested well in older adults. But the federal agency...
Ottumwa Courier
CDC vaccine policy recommendations grind to a halt under Health Secretary Kennedy
The Centers for Disease Control and Prevention’s vaccine recommendation process has been blown up in the past year, and decision-making has ground to a halt. Efforts by vaccine-wary officials in President Donald Trump's administration to scale back shot recommendations have…
Fox 10 Phoenix
FDA approves first mRNA flu vaccine, but CDC has yet to recommend it
The FDA has approved mFlusiva, the first mRNA flu vaccine, for adults ages 50 to 64, but the CDC has not added it to its recommended list amid legal uncertainties and disruptions to the federal vaccine review process.
CDC vaccine recommendations are at a standstill, and unanswered questions are piling up – WTOP News
NEW YORK (AP) — The Food and Drug Administration recently approved a new flu vaccine that tested well in older adults. But the federal agency responsible for telling doctors and the general public how to use it has made no recommendation on it. The Centers for Disease Control and Prevention’s inaction on the mFlusiva vaccine...
The Toronto Star
CDC vaccine recommendations are at a standstill, and unanswered questions are piling up
NEW YORK (AP) — The Food and Drug Administration recently approved a new flu vaccine that tested well in older adults. But the federal agency responsible for telling doctors and the general public how to use it has made no…
Coverage Details
Bias Distribution
- 51% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
